Vaccine vial maker Stevanato valued at over $5 bln in NYSE debut
Shares of Italy's Stevanato Group S.p.A. , which makes glass vials for COVID-19 vaccines and other healthcare products, fell more than 20% in their New York Stock Exchange debut on Friday, giving the company a market capitalization of over $5 billion.
ALSO READ
-
EIB and Intesa Sanpaolo Sign €300 Million Deal to Expand Affordable Housing in Italy
-
Italy and UN Partners Set Out Rome’s Growing Role as Global Development Finance Hub
-
Italy Mobilizes Navy to Secure Vital Shipping Lanes in Bab el-Mandeb
-
Italy Steps in as Final Stop for 2026 World Rally Championship
Google News